NPTN Neophotonics

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by NeoPhotonics Corporation and Certain Officers and Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of NeoPhotonics Corporation (“NeoPhotonics” or the “Company”) (NYSE:NPTN) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.

On December 19, 2016, post-market, NeoPhotonics announced the divestiture of the Company’s low-speed transceiver business. NeoPhotonics also forecast adjusted fourth-quarter earnings of $0.03 to $0.11 per share on revenue of $105 million to $109 million, citing delayed shipments from one of the Company’s new factories. On this news, NeoPhotonics stock has fallen as much as $2.39, or 19.14%, during intraday trading on December 20, 2016. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/neophotonics-nptn

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
20/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neophotonics

Neophotonics Corp: 1 director

A director at Neophotonics Corp sold after exercising options/sold 38,842 shares at 15.325USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

 PRESS RELEASE

NeoPhotonics 400G ZR Modules Support Extended Operation up to 80C Case...

SAN JOSE, Calif.--(BUSINESS WIRE)-- NeoPhotonics Corporation (NYSE: NPTN), a leading developer of silicon photonics and advanced hybrid photonic integrated circuit-based lasers, modules and subsystems for bandwidth-intensive, high speed communications networks, today announced availability of its extended case temperature QSFP-DD 400G ZR modules. This press release features multimedia. View the full release here: Shown are 36 NeoPhotonics QSFP-DD 400ZR Modules Operating in an Arista Switch (Photo: Business Wire) These 400G ZR modules utilize NeoPhotonics’ industry leading coherent optical comp...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: January 16, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: January 4, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch